Related Experiment Video
Updated: Feb 28, 2026
03:57
Author Spotlight: Exploring Corneal Innate Immunity and Delayed Wound Healing in Diabetic Patients
Published on: January 10, 2025
25.4K
Bioactive Antimicrobial Peptides as Therapeutics for Corneal Wounds and Infections
Gina L Griffith1, Anne Kasus-Jacobi2,3, H Anne Pereira2,3,4,5
1Ocular Trauma and Vision Restoration, United States Army Institute of Surgical Research, Fort Sam Houston, Texas.
Advances in Wound Care
|June 16, 2017
Summary
Antimicrobial peptides (AMPs) show promise for treating eye injuries and infections, offering dual action for corneal wound healing and infection clearance. This innovative approach addresses limitations in current therapeutics for vision loss.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Biomedical Engineering
Background:
- Millions of eye injuries and infections annually cause vision loss in the US.
- Current treatments for ocular injuries and infections are often inadequate.
- Effective and rapid therapeutics are crucial, especially for combat-related injuries.
Purpose of the Study:
- To review the potential of antimicrobial peptides (AMPs) as novel therapeutics for corneal wounds and infections.
- To highlight AMPs' dual capability in promoting corneal wound healing and combating infections.
- To discuss innovative approaches for treating ocular injuries and persistent corneal epithelial defects.
Main Methods:
- Review of current standard-of-care for ocular defects, infections, and inflammation.
- Exploration of recent advances in corneal wound healing therapies.
- Investigation of antimicrobial peptides (AMPs) as potential bioactive peptide therapeutics.
Main Results:
- Antimicrobial peptides (AMPs) offer a promising therapeutic strategy for ocular conditions.
- AMPs possess the dual capacity to accelerate corneal wound healing and eradicate infections.
- Bioactive peptides derived from natural antimicrobial proteins are being explored to fill therapeutic gaps.
Conclusions:
- Antimicrobial peptides (AMPs) represent a significant advancement in treating corneal wounds and infections.
- Developing AMP-based therapies could greatly benefit patients with ocular injuries, including those with delayed healing.
- Further research into AMPs holds potential for clinical breakthroughs in ophthalmology.
Related Concept Videos
01:23Antimicrobial Proteins
14.8K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
14.8K
01:18Surface Membrane Barriers
3.1K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
3.1K
01:19Clinical Applications of Epidermal Stem Cells
3.4K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.4K